Sotera Health director Krause files Form 3

Sotera Health Co filed an initial insider ownership report for Kenneth D. Krause, who is identified as a director of the company.

Accepted by SEC EDGAR 03/20/2026 - 04:53 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Sotera Health Co filed an initial insider ownership report for Kenneth D. Krause, who is identified as a director of the company. This Form 3 filing does not list any transactions or current holdings, serving mainly to register his status as a reporting insider under SEC rules.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Sotera Health Co (SHC) Form 3 filing for Kenneth D. Krause show?

The Form 3 shows that Kenneth D. Krause is a director of Sotera Health Co. It serves as his initial insider ownership report and, in this case, reports no transactions or specific holdings, simply establishing him as a reporting person under SEC rules.

Does the Sotera Health Co (SHC) Form 3 report any stock transactions by Kenneth D. Krause?

No, the Form 3 reports no stock transactions for Kenneth D. Krause. The transaction summary shows zero buys, sells, exercises, gifts, or other movements, indicating this filing only establishes his reporting status as a director of Sotera Health Co.

What insider role does Kenneth D. Krause have at Sotera Health Co (SHC)?

Kenneth D. Krause is reported as a director of Sotera Health Co. The filing indicates he is not listed as an officer or ten percent owner, so his reporting obligation arises from his board position rather than executive or large-shareholder status.

Are any derivative securities reported for Kenneth D. Krause in the Sotera Health (SHC) Form 3?

No derivative securities are reported for Kenneth D. Krause in this Form 3. The derivative summary is empty and the derivative transaction count is zero, indicating no options, warrants, or similar instruments are disclosed in this initial ownership statement.

Why is the Sotera Health Co (SHC) Form 3 for Kenneth D. Krause important to investors?

The Form 3 confirms that Kenneth D. Krause is an SEC-reporting insider as a director of Sotera Health Co. While it shows no holdings or trades, it establishes that future transactions by him will be reportable on Forms 4 or 5, improving transparency around insider activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Krause Kenneth D.

(Last) (First) (Middle)

C/O SOTERA HEALTH COMPANY

9100 SOUTH HILLS BLVD, SUITE 300

(Street)

BROADVIEW HEIGHTS OHIO 44147

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
Sotera Health Co [ SHC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24.1 - Power of Attorney

No securities are beneficially owned.

	Gregory S. Harvey, Attorney-in-Fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)